Doxercalciferol
Who holds supplier records for Doxercalciferol? 7 organisations hold a current record for Doxercalciferol: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), Switzerland (1), Taiwan (1), Netherlands (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Doxercalciferol: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/doxercalciferol
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Doxercalciferol. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 25148 · latest filing Mar 2011
- CERBIOS PHARMA SASwitzerland Company GMP cert on recordActive DMF 28353 · latest filing Jul 2014
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 22136 · latest filing Oct 2008
- Sai Life Sciences LimitedIndiaActive DMF 22120 · latest filing Oct 2008
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 25594 · latest filing Jan 2012
- TAPI NL BVNetherlandsActive DMF 15357 · latest filing Apr 2001
- Wuxi Fortune Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 37132 · latest filing Jun 2022
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Doxercalciferol are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- India · Inactive DMF 23233 · filed Apr 2010
- POLYMED THERAPEUTICS INCInactive DMF 22590 · filed Mar 2009
- CEDARBURG PHARMACEUTICALS LLCInactive DMF 15397 · filed Apr 2001
Overview
Doxercalciferol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200810).
Chemical identity
- IUPAC name
- trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- Canonical SMILES
- C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
- InChIKey
- HKXBNHCUPKIYDM-CGMHZMFXSA-N
- Synonyms
- 1-alpha-hydroxyergocalciferol, 1.alpha.-hydroxyergocalciferol, 1-.alpha.-hydroxyergocalciferol, 1.alpha.-hydroxyvitamin d2, 1-hydroxyergocalciferol, Doxercalciferol, GZ427397, Hectorol, TSA-840, 1alpha-Hydroxyergocalciferol, 1alpha-hydroxyvitamin D2, 1-alpha-Hydroxyvitamin D2
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Vitamin D2 Analog
- Chemical structure
- Ergocalciferols
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Doxercalciferol?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Doxercalciferol: ALP PHARM BEIJING CO LTD, CERBIOS PHARMA SA (Switzerland), Formosa Laboratories, Inc. (Taiwan), Sai Life Sciences Limited (India), Sun Pharmaceutical Industries Limited (India), TAPI NL BV (Netherlands) and Wuxi Fortune Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Doxercalciferol Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 25148), CERBIOS PHARMA SA (DMF 28353), Formosa Laboratories, Inc. (DMF 22136), Sai Life Sciences Limited (DMF 22120), Sun Pharmaceutical Industries Limited (DMF 25594), TAPI NL BV (DMF 15357) and Wuxi Fortune Pharmaceutical Co., Ltd. (DMF 37132). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Doxercalciferol records mean?
3 organisations have only inactive Type II DMFs for Doxercalciferol. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Doxercalciferol supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Doxercalciferol?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.